Ran Goshen, Israel


Ran serves as the Chief Medical Officer of Medial EarlySign.  Founded in 2009, Medial EarlySign applies advanced mathematical algorithms and artificial intelligence technology to detect early warning signals and health risks in simple medical data across billions of dormant medical records, spanning decades of information. By exposing these hidden signs, EarlySign helps practitioners and healthcare organizations to identify critical threats, leading to potentially life-changing diagnoses for millions of patients every single day.

Ran is a board certified gynecologic oncologist, committed to changing patient care and making precision medicine a reality. Over the last decade and a half, Ran served as a consultant to several venture capital firms and institutional investors regarding their investments in life sciences.  He was Chief Medical Officer of dbMotion, an international Health IT company, and later CEO of GIView, a medical device start up.  He founded Eliaso, the world’s most exclusive organization devoted to the needs of patients facing life-threatening diseases.  

Ran holds an MD from the Hadassah Medical School at the Hebrew University of Jerusalem.  He earned his board certification in Obstetrics and Gynecology from Hadassah Mount Scopus Hospital and was later certified as a Gynecologic Oncologist at the University of Toronto.  He earned a Ph.D. from the Hebrew University, his thesis focusing on a model of cell-cell interaction in cancer development. Ran published over 50 papers in peer-reviewed medical journals, as well as several chapters in books dealing with cancer and genetics.

Ran Goshen, MD, Ph.D.